Corrigendum: Thrombospondin-1 Silencing Down-Regulates Integrin Expression Levels in Human Anaplastic Thyroid Cancer Cells With BRAF<sup>V600E</sup>: New Insights in the Host Tissue Adaptation and Homeostasis of Tumor Microenvironment.

Duquette, Mark; Sadow, Peter M; Lawler, Jack; Nucera, Carmelo

Corrigendum: Thrombospondin-1 Silencing Down-Regulates Integrin Expression Levels in Human Anaplastic Thyroid Cancer Cells With BRAF^V600E: New Insights in the Host Tissue Adaptation and Homeostasis of Tumor Microenvironment.

Duquette, Mark; Sadow, Peter M; Lawler, Jack; Nucera, Carmelo.

Afiliação

Duquette M; Human Thyroid Cancers Preclinical and Translational Research Laboratory, Division of Cancer Biology and Angiogenesis, Department of Pathology, Harvard Medical School, Beth Israel Deaconess Medical Center (BIDMC), Boston, MA, United States.
Sadow PM; Endocrine Service, Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.
Lawler J; Division of Cancer Biology and Angiogenesis, Department of Pathology, Harvard Medical School, Center for Vascular Biology Research (CVBR), Beth Israel Deaconess Medical Center (BIDMC), Boston, MA, United States.
Nucera C; Human Thyroid Cancers Preclinical and Translational Research Laboratory, Division of Cancer Biology and Angiogenesis, Department of Pathology, Harvard Medical School, Beth Israel Deaconess Medical Center (BIDMC), Boston, MA, United States.

Front Endocrinol (Lausanne) ; 11: 596223, 2020.

Article em En | MEDLINE | ID: mdl-33162943